Skip to content

Perioperative Personalized Blood Pressure Management

Perioperative Personalized Blood Pressure Management in Patients Having Major Surgery: a Bicentric Prospective Randomized Controlled Interventional Pilot Trial (IMPROVE-pilot)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04894045
Enrollment
105
Registered
2021-05-20
Start date
2021-04-13
Completion date
2022-11-27
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Intraoperative Hypotension, Postoperative Complications

Keywords

Blood Pressure, Intraoperative Hypotension, Cardiovascular Dynamics

Brief summary

The investigators propose a pilot trial to (1) proof the concept that defining the intraoperative mean arterial pressure (MAP) intervention threshold based on the mean nighttime MAP (assessed using preoperative automated blood pressure monitoring) results in clinically relevant (mean nighttime MAP ± 10 mmHg) different target values compared with using an absolute population-derived MAP intervention threshold of 65 mmHg (primary endpoint); (2) investigate if a personalized perioperative blood pressure management is feasibly in multi-center studies, especially if the target values can be sufficiently achieved (secondary endpoint); (3) study the impact of personalized perioperative blood pressure management on the incidence of myocardial injury after non-cardiac surgery (MINS) (exploratory endpoint); (4) study the impact of personalized perioperative blood pressure management on the incidence of acute kidney injury within the first three postoperative days according to the KDIGO (Kidney Disease: Improving Global Outcomes) definition without oliguric criteria (exploratory endpoint).

Detailed description

not provided

Interventions

OTHERPersonalized management

Intraoperative MAP will be maintained at least at the mean nighttime MAP (assessed using preoperative automated blood pressure monitoring). If the mean nighttime MAP is below 65 mmHg, intraoperative MAP will be maintained at least at 65 mmHg.

Sponsors

RWTH Aachen University
CollaboratorOTHER
Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

In control group patients, the treating anesthesiologists are blinded to the data of preoperative automated blood pressure monitoring. Participants and outcomes assessors are blinded to group allocation.

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 45 * American Society of Anesthesiologists physical status class (ASA) II-IV * scheduled for elective major surgery under general anesthesia * surgery expected to last ≥ 120 minutes

Exclusion criteria

* emergency surgery * patients having liver or kidney transplantation * laparoscopic surgery * pregnancy * status of post transplantation of kidney, liver, heart, or lung * sepsis (according to current Sepsis-3 definition) * impossibility of preoperative automated blood pressure monitoring * MAP differences between the right and the left arm of more than 20 mmHg surgery that requires controlled hypotension

Design outcomes

Primary

MeasureTime frameDescription
Individualized MAP target value1 day before surgeryDifference between intraoperative target MAP (defined as the mean nighttime MAP assessed using preoperative automated blood pressure monitoring) and 65 mmHg; we consider a difference \> ± 10 mmHg as clinically meaningful.

Secondary

MeasureTime frameDescription
Proportion of patients with calculated MAP targetday of surgery\- proportion of patients in whom preoperative automated blood pressure monitoring + calculation of target MAP is possible
Duration and severity of MAP below MAP targetday of surgery\- time weighted average MAP below individual MAP target

Other

MeasureTime frameDescription
Incidence of myocardial injury after non-cardiac surgerybaseline, postoperative days 1, 2 and 3Incidence of myocardial injury after non-cardiac surgery assessed through measurement of baseline high-sensitivity troponin T (before surgery) and high-sensitivity troponin T on postoperative days 1,2, and 3.
Incidence of acute kidney injurybaseline, postoperative day 1, 2 and 3Incidence of acute kidney injury within the first three postoperative days according to the KDIGO definition without oliguric criteria assessed through measurement of baseline creatinine (before surgery) and creatinine after surgery on postoperative days 1, 2, and 3.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026